26/04/2026
SARD-ILD National Symposium, Mumbai
Systemic Autoimmune Rheumatic Diseases (SARD) related Interstitial Lung Disease (ILD), also known as Connective Tissue Disease associated ILD (CTD-ILD) is one of the leading cause of ILD in India.
Management is challenging and also rapidly evolving due to advances in availability of newer antibody testing panels and newer tailored treatment options.
Best results can be obtained by:
1. Multi-Disciplinary Discussion (MDD) among Pulmonologist, Rheumatologist, Radiologist and the Patient / Family
2. Strict and prolonged monitoring for evolution/ change in disease
3. Appropriate immunomodulators, anti-fibrotics, rehab and vaccinations.
4. Long term commitment to treatments.
Every patient is different; and treating team must optimise care of a given person. It takes time - and sustained efforts. But it absolutely worth it.
Today, I was speaking on 2 panels on RA-ILD and myositis-ILD from the Rheumatologist perspective.
It was great to be among learned colleagues and also my teachers from across the country.
For anyone suffering from ILD - take care, and ensure to see both the specialist (Pulmonologist & Rheumatologist).